DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $512,540 | -45.1% | 36,402 | -39.8% | 0.01% | -50.0% |
Q1 2023 | $934,262 | +149.8% | 60,470 | +165.0% | 0.03% | +136.4% |
Q4 2022 | $373,938 | -35.1% | 22,815 | -26.7% | 0.01% | -45.0% |
Q3 2022 | $576,000 | +311.4% | 31,138 | +117.8% | 0.02% | +122.2% |
Q4 2021 | $140,000 | -88.5% | 14,299 | -51.7% | 0.01% | -89.9% |
Q1 2020 | $1,220,000 | +141.1% | 29,634 | +264.5% | 0.09% | +196.7% |
Q4 2019 | $506,000 | +96.1% | 8,131 | +7.1% | 0.03% | +36.4% |
Q3 2019 | $258,000 | -37.2% | 7,593 | -57.1% | 0.02% | -24.1% |
Q1 2019 | $411,000 | +102.5% | 17,708 | +243.6% | 0.03% | +107.1% |
Q2 2018 | $203,000 | – | 5,153 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |